Supplier Type
- Manufacturer
- Trader
- contract manufacturer
- Reagent
- custom synthesis
Supplier Region
- Hyderabad(26)
- Gujarat(33)
- Maharashtra(29)
- Tamil Nadu(3)
- Mumbai(49)
- Ahmedabad(16)
- Rajasthan(1)
- New Delhi(3)
- Delhi(5)
- Haryana(5)
- Beijing(3)
- Uttar Pradesh(2)
- Bangalore(2)
- Pune(2)
- Vadodara(10)
- Karnataka(8)
- Telangana(3)
- Andhra Pradesh(2)
- Kerela(1)
- Kolkata(2)
- Nagpur(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- Powder 99%
- NLT 95%
- NLT 90%
- NA
- more than 95%
- more than 90%
- minimum 96%
- Min. 99.0%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- High
- Greater than 99%
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- Cytidine 5'-Monophosphate Disodium Salt (C9H14N3Na2O8P) - High-purity pharmaceutical-grade
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- ABOVE 99%
- 99.99%
- 99.98%
- 99.95%
- 99.93%
- 99.91%
- 99.90%
- 99.9%
- 99.86%
- 99.85%
- 99.73%
- 99.68%
- 99.60%
- 99.55 % MINIMUM
- 99.50%
- 99.5%
- 99.42%
- 99.34%
- 99.30%
- 99.29%
- 99% Min
- 99%
- >99%
- 99
- 98+
- 98.91%
- 98.70%
- 98.60%
- 98.58%
- 98.50%
- >98.5%
- 98.20%
- 98.12%
- 98.00%
- 98%
- >98%
- 98
- 97-99%
- 97.57%
- 97.51%
- 97.00%
- 97%
- >97%
- 97 %
- 96+1%
- 96.80%
- 96.64%
- 96.40%
- 96.39%
- 96% Minimum
- 96% - 104%
- 96%
- 96 %
- 95.00%
- 95% - 98%
- 95%
- >95%
- 95 %
- 94.25%
- 94.00%
- 93.21%
- 92.60%
- >92%
- 90% min
- >90%
- 90%
- 90 % Above
- 80% min
- 65%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 100%
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 0MG TO GRAM
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1gm
- 5g
- 10g
- 5kg
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 1g
- 25g
- 50g
- 100g
- 500g
- 1kg
- 10kg
- 25kg
- 50kg
- 500kg
- 1and gm
- 1MT
- 95NLT %
- 250250 mg.
- 11Between 1 gm to 1 MT (As per availability)
- 100kg
-
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-, sodium salt (1:1), (4S)-
77987-01-0
-
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, sodium salt (1:1), (4S)-
72517-83-0
-
[1,4'-Bipiperidine]-1'-carboxylic acid, (4S)-4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester, hydrochloride (1:1)
207683-84-9
-
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-, hydrochloride (1:1), (4S)-
1174930-07-4
-
Naproxen sodium
26159-34-2
-
Disodium hydrogen phosphate dihydrate
10028-24-7
-
6-NITRO-1,3-BENZOXAZOLE
30693-53-9
-
CONDURITOL B EPOXIDE
6090-95-5
-
Montelukast Acyl-b-D-glucuronide
188717-17-1
-
4-Amino-benzenesulfonic acid monosodium salt
515-74-2
Dimethyl 5,9-dihydroxy-7H-cyclohepta[b]pyridine-6,8- dicarboxylate 39713-36-5
Ethylenediamine-N,N,N',N'-tetraacetic acid tetrasodium salt 64-02-8
(4aR,7aR)-Octahydro-1H-Pyrrolo[3,4-b]pyridine 151213-42-2
(R)-BoroLeu-(+)-Pinanedioltrifluoroacetate salt 179324-87-9
Rhodamine B base 509-34-2
2-Naphthol-6,8-disulfonic acid dipotassium salt 842-18-2
Saccharin sodium salt 128-44-9
3-Nitrobenzenesulfonic acid sodium salt 127-68-4
2-Naphthol-6,8-disulfonic acid dipotassium salt 842-18-2